Download as PDF, PPTX
Uploaded byAlphaClone, Inc.
5 Myths About Cloning Hedge Funds
The document presents a webinar on the myths surrounding cloning hedge funds, featuring Maz Jadallah and moderated by Zack Miller. It addresses five specific myths, such as the perceived inefficacy of delayed disclosures and the notion that hedge fund outperformance is merely luck. The discussion emphasizes the importance of skill and strategy in investment performance and provides various data points to highlight the advantages of cloning investment strategies.
5 Myths About Cloning Hedge Funds
- 1. 5 MYTHS ABOUT CLONINGHEDGE FUNDS Future of Finance Webinar Series Presenter: Maz Jadallah, Founder/CEO, AlphaClone Moderator: Zack Miller, Author, Tradestreaming.com Date: May 9th @ 4pm EST, 1pm PST
- 2. important disclosures Investing infnancial markets involves risk, including the risk of principal loss. Information in this presentation is in no way intended as investment advice and should not be interpreted as such. Backtesting is the process of evaluating a core strategy by applying it to historical data. Backtested performance results are provided for purposes of illustrating historical performance had a core strategy had been available during the relevant period. Backtested performance results are hypothetical and have inherent limitations. AlphaClone makes no representation that any core strategy will achieve performance similar to any backtested performance results. Actual results could difer materially from backtested performance and future results could difer materially from backtested performance. Past performance is no indication or guarantee of future results. The information provided herein comes from what AlphaClone believes to be reliable sources. AlphaClone, however, makes no representations as to its reliability or accuracy, and you should undertake independent analysis to ensure the accuracy of the information. © 2010, AlphaClone LLC, All Rights Reserved. The AlphaClone logo is a service mark of AlphaClone LLC.
- 3. intro Zack Miller, Author,Tradestreaming.com Maz Jadallah, Founder/CEO, AlphaClone
- 4. clone? Quant investment strategy that derives buy/sell decisions from public disclosure filings
- 5. clone? ↂ rules based ↂ disclosure based ↂ automated ↂ repeatable
- 6. Myth #1 45 day delay in filing renders disclosures useless
- 7. 1/3 Average On average, 1 in 3 clone portfolios outperformed the S&P500 by 10 percentage points or more (2000 to 2010) Source: AlphaClone
- 8. clone vs. fund 2010 Fund Clone (net) (gross: long) Greenlight Capital 12.5% 21.3% Pershing Square 29.7% 25.9% Paulson & Co. 24% 19.4% Third Point 34% 25.8% Passport 18.3% 25.9% Perry Capital 14.6% 28.4% Source: AlphaClone, “Clone vs Fund 2010”
- 9. Myth #2 Many hedge fund trades are “crowded”
- 10. Implication Little guy getshurt when funds exit
- 11. 35% % Overlap 20 most popular hedge fund 30% AAPL holdings for Q4 2010* 25% C 20% GOOG 15% JPM BAC GENZ 10% GM POT WFC BIDU CCI WMB 5% 0% * Based on 178 hedge funds tracked by AlphaClone 0 5 10 15 20 25 Source: AlphaClone
- 12. % Overlap 3 most popular hedge fund holdings - Q3/99 to Q3/10 Most Crowded 2nd Most 3rd Most 35% 30% 25% 20% 15% 10% 5% Q1 00 Q1 01 Q1 02 Q1 03 Q1 04 Q1 05 Q1 06 Q1 07 Q1 08 Q1 09 Q1 10 Source: AlphaClone
- 13. Myth #3 Outperformance is due to luck
- 14. french/fama study “Luckvs. Skill In Mutual Fund Performance” 2% 2% Luck % of active mutual funds Skill % of active mutual funds expected to outperform if that actually selected randomly outperformed Source: Fama/French Forum, “Luck vs. Skill in Mutual Fund Performance”
- 15. clone universe -top 20 holdings “Luck vs. Skill” 2% 24% Luck % of active mutual Skill % of clones that outperformed funds expected to by 2+ standard deviations outperform if selected randomly
- 16.
- 17. Myth #4 All my alpha is in my “shorts”
- 18. clone vs. fund 2010 Fund Clone (net) (gross: long) Greenlight Capital 12.5% 21.3% Pershing Square 29.7% 25.9% Paulson & Co. 24% 19.4% Third Point 34% 25.8% Passport 18.3% 25.9% Perry Capital 14.6% 28.4% Source: AlphaClone, “Clone vs Fund 2010”
- 19. clone vs. fund(cont.) 2010 Fund Clone (net) (gross: long) Millennium Mgmt 13.3% 15.7% SAC Capital 15% 20.3% Tudor Capital 7.5% 10.8% Jana Partners 8.4% 13.7% Och-Ziff 8.4% 9.2% Bridgewater 38% 24.9% Source: AlphaClone, “Clone vs Fund 2010”
- 20. Myth #5 Hedge funds have very short holding periods
- 21. 1 Year Average hedge fund holding period Source: AlphaClone; Goldman Sachs
- 22. New Buys Rank +3 Mos. +12 Mos. Appaloosa MS 1 - - New buy retention XLE 3 - - Q4 2008 (crisis) GT 4 4 13 XL 5 6 18 S 7 - - ODP 13 13 27 OMX 16 15 29 BC 18 8 14 RAD 25 10 21 WLT 31 - - Retention 6/10 6/10 Source: AlphaClone
- 23. New Buys Rank +3 Mos. +12 Mos. Appaloosa WFC 3 2 2 New buy retention AMR 9 18 29 Q4 2009 UAL 10 14 17 DAL 11 19 38 WSH 12 15 41 RBS 17 20 31 LCC 20 26 32 NAV 24 16 35 HPT 26 - - COF 30 37 28 Retention 9/10 9/10 Source: AlphaClone
- 24. 5 cloning rules ↂ bottoms-up vs macro ↂ backtest: broad attribution ↂ fof mindset ↂ protect downside ↂ automate and stick with it
- 25.